We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...
Belen Garijo, the CEO of Merck KGaA, says focus on growth and innovation is key to the German group’s future.
Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some ...
Merck’s investigational antibody clesrovimab demonstrated more than 60% effectiveness in reducing some types of respiratory ...
While you may think of healthcare as only covering human health, animal and pet health is also a growing sector. Click to read.
GlobalData on MSN11h
MSD mulls 2025/26 launch for RSV vaccine after Phase II/III winA Phase IIb/III trial with infants entering their first respiratory syncytial virus (RSV) season met its primary endpoints.
Former LEO Pharma and Bayer executive Möller stepped into the CEO role in January after the departure of Joanna Shields last ...
We recently compiled a list of the 7 Blue Chip Stocks with Low PE Ratios. In this article, we are going to take a look at ...
Report on how AI is redefining market landscape - The Global Biopolymers Market size is estimated to grow by USD 17.11 ...
New data released by Merck suggests AstraZeneca and Sanofi’s Beyfortus, the monoclonal antibody injection that protects ...
After a prior rejection, Astellas can head into the weekend celebrating a class-first FDA approval for its new gastric cancer ...
Controlled release drug delivery market. Global Controlled Release Drug Delivery market Outlook 2024-2032: Rising Demand and Key Trends: Controlled release ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback